Burden of vaso‐occlusive crisis, its management and impact on quality of life of Indian sickle cell disease patients
Sickle cell disease (SCD) with vaso-occlusive pain crisis (VOC) significantly impacts patient well-being and often results in extensive healthcare resource utilization. This study assessed the VOC burden, its management and its impact on patients' quality of life (QoL). A cross-sectional observational study was conducted between November 2021 and June 2022, including 1000 SCD patients from high-prevalence states in India. Data on demographics, clinical characteristics, VOC severity, management and QoL were collected. The study revealed that 33.5% of patients reported at least one VOC episode during the study period. In the year prior to their enrolment, 836 (83.60%) patients reported at least one VOC episode, with an equal proportion of 407/487 (83.6%) adults and 429/513 (83.6%) paediatric patients, reducing their QoL across all domains compared to patients without VOC. Of these, 469/1000 patients (46.9%) experienced ≥3 VOC episodes. Additionally, 764/1000 (76.40%) patients managed their VOCs at healthcare facilities, with 501/1000 (50.1%) requiring inpatient admissions. Further, 71.80% of patients received Hydroxyurea (HU) therapy. The study depicts the severity of the Arab-Indian haplotype in Indian SCD patients visiting healthcare settings based on high VOC burden. This highlights the urgent need for better management strategies and resource allocation for these patients.
Authors
- Tuphan Kanti Dolai (ORCID: https://orcid.org/0000-0001-8842-6257)
- Shashank Udupi (ORCID: https://orcid.org/0000-0001-8025-4884)
- Bharat Parmar
- Disha Shetty (ORCID: https://orcid.org/0000-0001-6774-6980)
- Deepa Bhat (ORCID: https://orcid.org/0000-0002-4928-1718)
- Suman Jain (ORCID: https://orcid.org/0000-0001-6237-1913)
- Anil Kumar Goel (ORCID: https://orcid.org/0000-0001-8519-5684)
- Anupam Dutta (ORCID: https://orcid.org/0000-0001-9520-5196)
- Seema S. Bhatwadekar
- Tulika Seth (ORCID: https://orcid.org/0000-0001-9760-7957)
- Dipty Jain (ORCID: https://orcid.org/0000-0002-8628-4977)
- Shomik Ray (ORCID: https://orcid.org/0000-0001-9345-8982)
- Ashvin Vasava
- Ravindra Kumar (ORCID: https://orcid.org/0000-0001-9469-8080)
- Riya Ballikar
- Rabindra Kumar Jena (ORCID: https://orcid.org/0000-0001-9525-3016)
- Priyanka Samal (ORCID: https://orcid.org/0000-0002-9129-7967)
- Nandakumar Menon (ORCID: https://orcid.org/0000-0002-0363-1532)
- Manish Mistry
- Jina Bhattacharyya (ORCID: https://orcid.org/0000-0002-6066-6491)
Institutions
- All India Institute of Medical Sciences Raipur (IN)
- Gauhati Medical College and Hospital (IN)
- Nil Ratan Sircar Medical College and Hospital (IN)
- Sriram Chandra Bhanja Medical College Hospital (IN)
- Midas Multispeciality Hospital (IN)
- Novartis (India) (IN)
- National Institute for Research in Tribal Health (IN)
- Government Medical College (IN)
- Ashwini Hospital (IN)
- Institute of Medical Sciences and Sum Hospital (IN)
- All India Institute of Medical Sciences (IN)
- Medical College and Hospital, Kolkata (IN)
- Public Health Foundation of India (IN)
- Assam Medical College (IN)
- JSS Medical College and Hospital (IN)
Publication Details
- Journal
- British Journal of Haematology
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1111/bjh.19829
- Citations
- 7
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.07